---
$id: https://graph.org.ai/products/commodity/51372203
$type: Product
source: UNSPSC
code: "51372203"
title: "Levomoramide"
class: "51372200"
classTitle: "Controlled substance analgesic morpholines"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levomoramide

**UNSPSC Code**: 51372203
**Class**: [Controlled substance analgesic morpholines](Controlled substance analgesic morpholines.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C25H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7M86YFN15D, chemically known as pyrrolidine, 1-(3-methyl-4-(4-morpholinyl)-1-oxo-2,2-diphenylbutyl)-, (s)- but generally known as levomoramide, which bears US NIH Compound Identifier 9648. European Medicines Agency schedules Levomoramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08481MIG. The term LEVOMORAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). LEVOMORAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levomoramide under HS 29349990 and SITC 51579. As of Q4 2014, LEVOMORAMIDE remains the US FDA Preferred Term for this commodity. Levomoramide bears US NLM identifiers UMLS ID C0608090 and NCI Concept Code C83878. SMILES: O=C(N1CCCC1)C(C(CN1CCOCC1)C)(C1CCCCC1)C1CCCCC1.

